Cannabidiol for Reducing Cigarette Use (NCT06218056)
Evaluating the Efficacy of Cannabidiol for Reducing Cigarette Use
🩺 Plain-English Summary (8th-Grade Level)
The goal of this research is to evaluate the efficacy of cannabidiol (CBD) in reducing cigarette smoking. Although there are safe and effective treatments for smoking cessation, not everyone who attempts smoking cessation is successful, even with these treatments. Relapse rates are high, leaving a need for new approaches. Despite justification to evaluate CBD for this indication, human research on the topic is scant. Larger, more extended studies are warranted and essential. The investigators will recruit participants from CRI-Help, Inc., a substance abuse treatment program in North Hollywood, where residents who indicate the desire to stop smoking are prohibited from using other cannabis products which would affect recruitment. The aims of this study are: 1. Evaluate the effects of CBD on nicotine intake. 2. Exploratory Aims. Measure plasma concentrations of CBD, N-arachidonoyl-ethanolamine (anandamide) and 2-arachidonoylglycerol (2-AG) at baseline and day 7. Participants who meet eligibility criteria will take part in a 56-day treatment phase during which they receive the study medication under supervision (CBD or placebo twice daily) and complete questionnaires on side effects, withdrawal, craving and mood symptoms. Blood, breath, and urine tests will also be performed throughout the study. Participants who complete the treatment will also be assessed at 1-month and 3-month follow up visits.
Who can join: Review the eligibility criteria below.
Location: CRI-Help, Inc. — North Hollywood, California
Age range: 18 Years to 65 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- CRI-Help, Inc. — North Hollywood, California
📞 Contact the Study Coordinator
Phone: (310) 825-0606
Email: ELondon@mednet.ucla.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Tobacco Use Disorder
- Nicotine Replacement Therapy Prescribing and Lung Cancer Screening in Hospitalized Patients — Charleston, South Carolina
- Abstinence Reinforcement Therapy for Veterans Who Smoke Tobacco and Are Experiencing Homelessness — Durham, North Carolina
- 5-HT2A Agonist Psilocybin in the Treatment of Tobacco Use Disorder — Birmingham, Alabama
- Smoking Cessation Behavioral Treatment Study — Columbia, Missouri
- Beta-Adrenergic Modulation of Drug Cue Reactivity — Tulsa, Oklahoma
- An fMRI Study of the Effects of Clavulanic Acid on Drug Addiction — Columbia, Missouri
Explore by condition: All Tobacco Use Disorder clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.